Literature DB >> 7537246

dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor.

T Pham1, A Kaul, A Hart, P Goluszko, J Moulds, S Nowicki, D M Lublin, B J Nowicki.   

Abstract

Bacterial adhesins are important virulence factors that allow colonization of the human urogenital tract by Escherichia coli. Adhesins of the Dr family have been found to be more frequently expressed in strains associated with symptomatic urinary tract infections. Because of the high frequency of symptomatic urinary tract infections during pregnancy, we screened E. coli isolates from 64 gestational pyelonephritis patients for the expression of Dr and X adhesins to address their potential virulence roles in this population. Using PCR and primers for the afaB gene, we detected dra-related operons in 17 isolates (27%). On the basis of the lack of hemagglutination of Dr(a-) erythrocytes containing a point mutation in the decay-accelerating factor (DAF) short consensus repeat-3 (SCR-3) domain, 12 of these strains were categorized as classical Dr adhesins. The hemagglutination of O erythrocytes by Dr+ strains was blocked or reduced by a monoclonal antibody to the DAF SCR-3 domain. The remaining five dra-positive strains agglutinated Dr(a-) erythrocytes. Monoclonal antibody to the DAF SCR-3 domain failed to block O-erythrocyte hemagglutination. Adhesins in these strains did not fulfill criteria for Dr hemagglutinins because of the undefined receptor specificities and were categorized as X. E. coli strains bearing dra-related X adhesins bound to DAF cDNA-transfected Chinese hamster ovary cells. Three of these dra-related X-adhesin-bearing E. coli strains failed to attach to the SCR-3 delta deletion transfectant, which suggested that binding sites were located in the SCR-3 domain but outside the region blocked by the monoclonal anti-SCR-3 immunoglobulin G. The binding sites of the remaining two dra-related X adhesin strains were localized to the SCR-4 domain, as the attachment was shown to be abolished on an SCR-4 delta mutant but unaffected by an SCR-3 delta deletion. The heterogeneity in the binding sites of E. coli DAF (Dr) family adhesins from gestational pyelonephritis isolates may reflect the ability of the adhesins to evolve to recognize alternate peptide epitopes for efficient colonization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537246      PMCID: PMC173207          DOI: 10.1128/iai.63.5.1663-1668.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Gestational age-dependent distribution of Escherichia coli fimbriae in pregnant patients with pyelonephritis.

Authors:  B Nowicki; M Martens; A Hart; S Nowicki
Journal:  Ann N Y Acad Sci       Date:  1994-08-15       Impact factor: 5.691

Review 2.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

3.  Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.

Authors:  K E Coyne; S E Hall; S Thompson; M A Arce; T Kinoshita; T Fujita; D J Anstee; W Rosse; D M Lublin
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

4.  Interleukin-8 and the neutrophil response to mucosal gram-negative infection.

Authors:  W W Agace; S R Hedges; M Ceska; C Svanborg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction.

Authors:  C Le Bouguenec; M Archambaud; A Labigne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Decay-accelerating factor is expressed in the human endometrium and may serve as the attachment ligand for Dr pili of Escherichia coli.

Authors:  A Kaul; B J Nowicki; M G Martens; P Goluszko; A Hart; M Nagamani; D Kumar; T Q Pham; S Nowicki
Journal:  Am J Reprod Immunol       Date:  1994-10       Impact factor: 3.886

7.  Diffuse-adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico.

Authors:  J A Girón; T Jones; F Millán-Velasco; E Castro-Muñoz; L Zárate; J Fry; G Frankel; S L Moseley; B Baudry; J B Kaper
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

8.  Characterization of plasmid-borne afa-3 gene clusters encoding afimbrial adhesins expressed by Escherichia coli strains associated with intestinal or urinary tract infections.

Authors:  C Le Bouguenec; M I Garcia; V Ouin; J M Desperrier; P Gounon; A Labigne
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.

Authors:  D M Lublin; K E Coyne
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.

Authors:  B Nowicki; A Hart; K E Coyne; D M Lublin; S Nowicki
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  23 in total

1.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Pyelonephritogenic diffusely adhering Escherichia coli EC7372 harboring Dr-II adhesin carries classical uropathogenic virulence genes and promotes cell lysis and apoptosis in polarized epithelial caco-2/TC7 cells.

Authors:  J Guignot; J Breard; M F Bernet-Camard; I Peiffer; B J Nowicki; A L Servin; A B Blanc-Potard
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.

Authors:  B Nowicki; J Singhal; L Fang; S Nowicki; C Yallampalli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains.

Authors:  Patrick Brest; Frédéric Bétis; Nicolas Cuburu; Eric Selva; Magali Herrant; Alain Servin; Patrick Auberger; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Molecular aspects of biogenesis of Escherichia coli Dr Fimbriae: characterization of DraB-DraE complexes.

Authors:  Rafal Piatek; Beata Zalewska; Olga Kolaj; Michal Ferens; Bogdan Nowicki; Józef Kur
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor.

Authors:  T Q Pham; P Goluszko; V Popov; S Nowicki; B J Nowicki
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

7.  Structural and functional lesions in brush border of human polarized intestinal Caco-2/TC7 cells infected by members of the Afa/Dr diffusely adhering family of Escherichia coli.

Authors:  I Peiffer; J Guignot; A Barbat; C Carnoy; S L Moseley; B J Nowicki; A L Servin; M F Bernet-Camard
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 8.  Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy.

Authors:  Patricia Brown; Moran Ki; Betsy Foxman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  A gene signature for post-infectious chronic fatigue syndrome.

Authors:  John W Gow; Suzanne Hagan; Pawel Herzyk; Celia Cannon; Peter O Behan; Abhijit Chaudhuri
Journal:  BMC Med Genomics       Date:  2009-06-25       Impact factor: 3.063

10.  Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55.

Authors:  Sylvie Hudault; O Brad Spiller; B Paul Morgan; Alain L Servin
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.